ROME (July 14, 2025) – Tesla BioHealing, a company using natural materials to create a biophoton-rich environment that promotes optimal well-being, shared a keynote presentation by Dr. James Z. Liu, the company’s founder and CEO, at the Second World Conference on Aging and Gerontology.
Representing the First Institute of All Medicines and Tesla BioHealing, Dr. Liu shared pilot study results showing an increase in CD34+ stem cells among 69 participants who used four Tesla BioHealing biophoton generators nightly for two weeks.
The randomized controlled study suggests biophoton exposure may offer a safe, drug-free approach to regenerative medicine by supporting the body’s natural ability to heal and slow the effects of aging.
“It’s a privilege to share the work we’re doing at Tesla BioHealing with audiences around the world,” said Dr. Liu. “Presenting our approach to anti-aging and regenerative medicine here in Rome marks an exciting milestone in our ongoing journey.”
Forward-Looking Statement This press release contains forward-looking statements that involve certain risks and uncertainties. These statements include, but are not limited to, potential benefits of Tesla BioHealing® products. Factors that could cause actual results to differ materially include risks that clinical development activities may be delayed or unsuccessful, that products may not be approved or commercially viable, and that regulatory decisions may be unfavorable. Tesla BioHealing Inc. and the First Institute of All Medicines (FIAM) disclaim any obligation to update these statements after the date hereof, except as required by law.